ULTRASOUND GUIDED THERAPEUTIC EXCISIONAL VACUUM ASSISTED BIOPSY IN FIBROADENOMA (BIRAD3 LESIONS)

Background: Ultrasound-guided, vacuum-assisted excision can play an efficient role in the diagnosis of benign breast lesions and is a safe and successful alternative treatment of fibroadenomas. Although the breast fibroadenoma is a common benign breast tumor, the treatment and follow-up of these lesions is still debatable. Ultrasound guided therapeutic excisional vacuum assisted biopsy has a well-documented role in the diagnosis of breast lesions, may provide an option for the definitive treatment of breast fibroadenomas. Objective: To evaluate ultrasound-guided, vacuum-assisted excision as an alternative approach in the diagnosis of radiologically benign breast lesions. Methods: This prospective study evaluated breast lesions excised using vacuum-assisted biopsy between April -October 2025 at Al Jumhori Teaching hospital/ radiology department. Patients with proven diagnosis of fibroadenoma were included in the study. All patients have been subjected to breast ultrasound examination. Results: Thirteen patients developed hematomas during Ultrasound guided therapeutic excisional vacuum assisted biopsy but none needed surgical intervention, while twelve patients pass with no significant hematomas, with 100% cure rate. None of the patients experienced significant enough pain to require the cessation of the procedure, although 22 (88%) patients reported mild pain and moderate pain (12%) during procedure. At the two-week control, 3 (12%) patients reported taking paracetamol for mild pain. In ten of them (40%) the pain was strong enough to interfere with sleep. Conclusion: Vacuum assisted Ultrasound-guided biopsy allows real-time imaging, could be performed without breast compression, and is the preferred method if the lesion is detectable with ultrasound.